Phares W, Franza B R, Herr W
Cold Spring Harbor Laboratory, New York 11724.
J Virol. 1992 Dec;66(12):7490-8. doi: 10.1128/JVI.66.12.7490-7498.1992.
The kappa B transcriptional enhancer motif, present in many viruses, is broadly active in many cell types. It is recognized by c-Rel/HIVEN86A in DNA affinity precipitation (DNAP) assays and by the Rel-related p50 and p65 subunits of the nuclear factor NF-kappa B in electrophoretic mobility shift assays (EMSA). We have analyzed activities that bind the human immunodeficiency virus type 1 and simian virus 40 kappa B motifs in two human leukemia cell lines, Jurkat and H9. In both DNAP and EMSA analyses of Jurkat cell extracts, we detected multiple kappa B motif-binding activities in addition to c-Rel/HIVEN86A and p50-p65 NF-kappa B. In Jurkat cell nuclear extracts, EMSA analysis revealed at least six specific DNA-protein complexes, of which one comigrated with the p50-p65 NF-kappa B complex. Formation of all six complexes was enhanced by stimulation of the cells with phorbol 12-myristate-13-acetate and phytohemagglutinin but was differentially affected by the salt concentration in the binding reaction and by the conditions of Jurkat cell growth. Nuclear extracts from both unstimulated and stimulated H9 cells revealed similar levels of five kappa B motif-specific complexes, all of which displayed mobilities distinct from those of the Jurkat cell complexes. Indeed, a complex corresponding to p50-p65 NF-kappa B was not detectable in nuclear extracts from unstimulated H9 cells although such a complex was apparent in nuclear extracts from stimulated H9 cells. In contrast to the inducibility of a p50-p65 NF-kappa B-like complex, transcriptional enhancers composed of multimerized kappa B motifs displayed similar high levels of activity in both the unstimulated and stimulated H9 cells. Thus, the activity of the kappa B motif in H9 cells corresponded to the abundance of the H9 cell-specific kappa B motif complexes and not to the levels of p50-p65 NF-kappa B complex. These results suggest that the broad activity of the kappa B enhancer element is not only due to the broadly distributed NF-kappa B activator but also to cell type-specific kappa B motif-binding activities.
κB转录增强子基序存在于多种病毒中,在许多细胞类型中广泛具有活性。在DNA亲和沉淀(DNAP)试验中,它可被c-Rel/HIVEN86A识别;在电泳迁移率变动分析(EMSA)中,它可被核因子NF-κB的Rel相关p50和p65亚基识别。我们分析了在两种人类白血病细胞系Jurkat和H9中与人类免疫缺陷病毒1型和猿猴病毒40 κB基序结合的活性。在对Jurkat细胞提取物进行的DNAP和EMSA分析中,除了c-Rel/HIVEN86A和p50-p65 NF-κB外,我们还检测到多种κB基序结合活性。在Jurkat细胞核提取物中,EMSA分析揭示了至少六种特异性DNA-蛋白质复合物,其中一种与p50-p65 NF-κB复合物迁移率相同。用佛波醇12-肉豆蔻酸酯-13-乙酸酯和植物血凝素刺激细胞可增强所有六种复合物的形成,但结合反应中的盐浓度以及Jurkat细胞的生长条件对其有不同影响。未刺激和刺激后的H9细胞核提取物显示出相似水平的五种κB基序特异性复合物,所有这些复合物的迁移率都与Jurkat细胞复合物不同。实际上,在未刺激的H9细胞核提取物中检测不到对应于p50-p65 NF-κB的复合物,尽管在刺激后的H9细胞核提取物中这种复合物很明显。与p50-p65 NF-κB样复合物的可诱导性相反,由多聚化κB基序组成的转录增强子在未刺激和刺激后的H9细胞中均显示出相似的高活性水平。因此,H9细胞中κB基序的活性与H9细胞特异性κB基序复合物的丰度相对应,而不是与p50-p65 NF-κB复合物的水平相对应。这些结果表明,κB增强子元件的广泛活性不仅归因于广泛分布的NF-κB激活剂,还归因于细胞类型特异性的κB基序结合活性。